|19th October 2020||David Portnoy||2,000||Open or private purchase||$6.94||$13,880.00|
|14th August 2020||George Gaines||760||Open or private sale||$8.80||$6,688.00|
|14th August 2020||George Gaines||3,615||Open or private sale||$9.00||$32,535.00|
|13th August 2020||George Gaines||120||Open or private sale||$9.33||$1,119.60|
|13th August 2020||George Gaines||100||Open or private sale||$9.30||$930.00|
|12th August 2020||George Gaines||2,878||Open or private sale||$9.60||$27,628.80|
|10th August 2020||David Portnoy||6,000||Open or private purchase||$9.00||$54,000.00|
|10th August 2020||Brian L. Sheehy||6,455||Open or private purchase||$9.00||$58,070.47|
|7th August 2020||David Portnoy||1,000||Open or private purchase||$8.89||$8,890.00|
|7th August 2020||David Portnoy||300||Open or private purchase||$8.80||$2,640.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Cyo-Cell International, Inc. engages in providing stem cell cryopreservation service and to advance regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage; and Prepacyte CB. The Cellular Processing segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells.